Loss Of Mhc Class 1 Expression Is Associated With Shorter Progression-Free Survival In Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors

MODERN PATHOLOGY(2021)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要